Together with the similar in vitro hERG inhibitory activity as BDQ lower metabolite exposure indicated a better cardiac safety potential of WX-081, although the sample size of MDR-TB patients in phase II study is limited and may be insufficient to conclude the safety profiles of WX-081. Here, KCNH2 is linked to tuberculosis.